Meyka Pro banner
Resverlogix Corp.

Resverlogix Corp. Fundamental Analysis (TSX: RVX.TO)

RVX.TOTSX
HealthcareBiotechnology
$0.10
$0.005(5.000%)
Canadian Market opens in 14h 45m

Resverlogix Corp. Fundamental Analysis (TSX: RVX.TO)

Resverlogix Corp. (TSX: RVX.TO) shows moderate financial fundamentals with a PE ratio of -2.19, profit margin of 0.00%, and ROE of 10.92%. The company generates N/A in annual revenue with weak year-over-year growth of 0.00%.

Key Strengths

PEG Ratio0.08

Areas of Concern

Operating Margin0.00%
Cash Position0.26%
Current Ratio0.04
We analyze RVX.TO's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 39.3/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
39.3/100

We analyze RVX.TO's fundamental strength across five key dimensions:

Efficiency Score

Weak

RVX.TO struggles to generate sufficient returns from assets.

ROA > 10%
-1.31%

Valuation Score

Excellent

RVX.TO trades at attractive valuation levels.

PE < 25
-2.19
PEG Ratio < 2
0.08

Growth Score

Weak

RVX.TO faces weak or negative growth trends.

Revenue Growth > 5%
0.00%
EPS Growth > 10%
-0.36%

Financial Health Score

Moderate

RVX.TO shows balanced financial health with some risks.

Debt/Equity < 1
-0.82
Current Ratio > 1
0.04

Profitability Score

Weak

RVX.TO struggles to sustain strong margins.

ROE > 15%
10.92%
Net Margin ≥ 15%
0.00%
Positive Free Cash Flow
No

Key Financial Metrics

Is RVX.TO Expensive or Cheap?

P/E Ratio

RVX.TO trades at -2.19 times earnings. This suggests potential undervaluation.

-2.19

PEG Ratio

When adjusting for growth, RVX.TO's PEG of 0.08 indicates potential undervaluation.

0.08

Price to Book

The market values Resverlogix Corp. at -0.27 times its book value. This may indicate undervaluation.

-0.27

EV/EBITDA

Enterprise value stands at 14.30 times EBITDA. This signals the market has high growth expectations.

14.30

How Well Does RVX.TO Make Money?

Net Profit Margin

For every $100 in sales, Resverlogix Corp. keeps $0.00 as profit after all expenses.

0.00%

Operating Margin

Core operations generate 0.00 in profit for every $100 in revenue, before interest and taxes.

0.00%

ROE

Management delivers $10.92 in profit for every $100 of shareholder equity.

10.92%

ROA

Resverlogix Corp. generates $-1.31 in profit for every $100 in assets, demonstrating efficient asset deployment.

-1.31%

Following the Money - Real Cash Generation

FCF Per Share

Each share generates $-0.01 in free cash annually.

$-0.01

FCF Yield

RVX.TO converts -17.23% of its market value into free cash.

-17.23%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-2.19

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

0.08

vs 25 benchmark

P/B Ratio

Price to book value ratio

-0.27

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.00

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

-0.82

vs 25 benchmark

Current Ratio

Current assets to current liabilities

0.04

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.11

vs 25 benchmark

ROA

Return on assets percentage

-1.31

vs 25 benchmark

ROCE

Return on capital employed

0.14

vs 25 benchmark

How RVX.TO Stacks Against Its Sector Peers

MetricRVX.TO ValueSector AveragePerformance
P/E Ratio-2.1932.02 Better (Cheaper)
ROE10.92%569.00% Weak
Net Margin0.00%29948.00% Weak
Debt/Equity-0.820.53 Strong (Low Leverage)
Current Ratio0.045.67 Weak Liquidity
ROA-131.48%-98.00% (disorted) Weak

RVX.TO outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Resverlogix Corp.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

0.00%

Industry Style: Defensive, Growth, Innovation

Declining

EPS CAGR

-255307.86%

Industry Style: Defensive, Growth, Innovation

Declining

FCF CAGR

-67262.45%

Industry Style: Defensive, Growth, Innovation

Declining

Fundamental Analysis FAQ